Financials
- Market Capitalization 11.42 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-37.39
ratio cours/chiffre d'affaires
16.85
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 806 | CORT Corcept Therapeutics Incorporated - Common Stock | 114.48 USD | +1.00% | -7.78% | +0.28% | +56.03% | 12.38 B USD | ||
| 814 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.49 USD | +1.08% | -1.92% | +28.92% | +59.42% | 12.09 B USD | ||
| 847 | TECH Bio-Techne Corp - Common Stock | 72.31 USD | 0.00% | -0.04% | +0.24% | +33.49% | 11.34 B USD | ||
| 866 | SMMT Summit Therapeutics Inc. - Common Stock | 13.55 USD | -0.51% | +3.59% | +4.63% | -31.77% | 10.81 B USD |